Ginacor

Ginacor is a clinical-stage medical technology company focused on developing innovative treatments for heart failure. The company's primary focus is on Heart Failure with Preserved Ejection Fraction (HFpEF), a condition characterized by stiffening of the heart muscle. Its lead product, G-Armor, is a proprietary epicardial implant designed to provide mechanical support to the left ventricle. By reducing myocardial wall stress, the device aims to halt or reverse adverse cardiac remodeling and improve overall heart function. The G-Armor system is designed for minimally invasive delivery, offering a potentially safer alternative to traditional cardiac surgeries. Headquartered in Israel, Ginacor was founded by experienced medical device entrepreneurs and is currently validating its technology through clinical trials.